Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
European Journal of Clinical Pharmacology|January 1, 1987
Pharmacokinetics of bendazac-lysine and 5-hydroxybendazac in patients with renal insufficiencyV Rovei, G Campistron, J M Dueymes, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 1, 1980
Long-term monitoring of tricyclic antidepressant plasma concentrationsH Loo, A K Benyacoub, V Rovei, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Effect of a reversible and selective MAO-A inhibitor (cimoxatone) on diurnal variation in plasma prolactin level in manM Strolin Benedetti, A Eschalier, A Lesage, et al.
Acta Cardiologica|January 1, 1980
Pharmacokinetics and metabolism of diltiazem in manV Rovei, R Gomeni, M Mitchard, et al.
La Nouvelle Presse Medicale|June 26, 1982
[Plasma level monitoring of psychotropic drugs in children. II -- Antidepressants (author's transl)]M Dugas, E Zarifian, M F Le Heuzey, et al.
L'Encephale|January 1, 1983
[Antidepressive action, pharmacokinetic characteristics and biochemical properties of cimoxatone, a new reversible MAO-A inhibitor]M F Poirier, J P Olié, H Lôo, et al.
Psychopharmacology|January 1, 1980
Comparison of single-dose pharmacokinetics of imipramine and maprotiline in the elderlyP D Hrdina, V Rovei, J F Henry, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profileD Caille, O E Bergis, C Fankhauser, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2005
Preserved insulin sensitivity and {beta}-cell activity, but decreased glucose effectiveness in normal-weight women with the polycystic ovary syndromeG Gennarelli, V Rovei, R F Novi, et al.
Pageof 4